CLOBETASOL PROPIONATE

N/A

Manufactured by Galderma Laboratories, L.P.

20,397 FDA adverse event reports analyzed

Last updated: 2026-04-14

About CLOBETASOL PROPIONATE

CLOBETASOL PROPIONATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Galderma Laboratories, L.P.. The most commonly reported adverse reactions for CLOBETASOL PROPIONATE include DRUG INEFFECTIVE, PRURITUS, PSORIASIS, OFF LABEL USE, RASH. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CLOBETASOL PROPIONATE.

Top Adverse Reactions

DRUG INEFFECTIVE1,103 reports
PRURITUS813 reports
PSORIASIS666 reports
OFF LABEL USE649 reports
RASH593 reports
FATIGUE511 reports
HEADACHE498 reports
NAUSEA477 reports
PRODUCT USE IN UNAPPROVED INDICATION474 reports
DIARRHOEA457 reports
ARTHRALGIA430 reports
PAIN399 reports
SKIN EXFOLIATION358 reports
DRY SKIN331 reports
ERYTHEMA328 reports
CONDITION AGGRAVATED322 reports
DYSPNOEA303 reports
INJECTION SITE PAIN297 reports
PAIN IN EXTREMITY288 reports
PRODUCT DOSE OMISSION ISSUE285 reports
DIZZINESS277 reports
DERMATITIS ATOPIC253 reports
VOMITING249 reports
FALL248 reports
PYREXIA230 reports
MALAISE229 reports
ECZEMA228 reports
INSOMNIA222 reports
ASTHENIA213 reports
BACK PAIN202 reports
WEIGHT DECREASED202 reports
ALOPECIA198 reports
ANXIETY196 reports
DEPRESSION196 reports
PRODUCT USE ISSUE189 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION185 reports
COUGH181 reports
PNEUMONIA177 reports
PERIPHERAL SWELLING165 reports
PSORIATIC ARTHROPATHY156 reports
SKIN FISSURES156 reports
URTICARIA148 reports
DECREASED APPETITE147 reports
HYPERTENSION146 reports
MYALGIA145 reports
NASOPHARYNGITIS144 reports
COVID 19143 reports
HYPERSENSITIVITY138 reports
MUSCLE SPASMS138 reports
URINARY TRACT INFECTION138 reports
FEELING ABNORMAL137 reports
GAIT DISTURBANCE136 reports
WEIGHT INCREASED132 reports
ABDOMINAL DISCOMFORT130 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION127 reports
INCORRECT DOSE ADMINISTERED124 reports
DEATH123 reports
DRUG HYPERSENSITIVITY121 reports
BURNING SENSATION120 reports
INFECTION120 reports
SINUSITIS120 reports
SKIN ATROPHY116 reports
NEUROPATHY PERIPHERAL115 reports
ABDOMINAL PAIN UPPER112 reports
CHEST PAIN111 reports
HYPOAESTHESIA110 reports
BLISTER109 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE109 reports
ABDOMINAL PAIN108 reports
CONSTIPATION108 reports
SKIN BURNING SENSATION108 reports
CONTUSION107 reports
DRY EYE107 reports
SKIN DISCOLOURATION106 reports
BLOOD PRESSURE INCREASED101 reports
VISION BLURRED101 reports
PARAESTHESIA100 reports
SKIN HAEMORRHAGE100 reports
JOINT SWELLING99 reports
RASH PRURITIC99 reports
OEDEMA PERIPHERAL98 reports
ILLNESS97 reports
TREATMENT FAILURE95 reports
ANAEMIA94 reports
INJECTION SITE ERYTHEMA93 reports
SYNCOPE93 reports
MYOCARDIAL INFARCTION92 reports
CELLULITIS90 reports
UPPER RESPIRATORY TRACT INFECTION90 reports
ACCIDENTAL EXPOSURE TO PRODUCT88 reports
ARTHRITIS88 reports
MUSCULAR WEAKNESS87 reports
RENAL FAILURE87 reports
HYPERHIDROSIS83 reports
INFLUENZA83 reports
INJECTION SITE SWELLING81 reports
RASH ERYTHEMATOUS81 reports
STRESS81 reports
DYSURIA80 reports
EYE PAIN79 reports

Report Outcomes

Out of 10,408 classified reports for CLOBETASOL PROPIONATE:

Serious 47.8%Non-Serious 52.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female5,932 (63.3%)
Male3,432 (36.6%)
Unknown12 (0.1%)

Reports by Age

Age 65205 reports
Age 62170 reports
Age 63170 reports
Age 55162 reports
Age 58162 reports
Age 64150 reports
Age 67148 reports
Age 68147 reports
Age 54144 reports
Age 73144 reports
Age 66143 reports
Age 57141 reports
Age 70140 reports
Age 61138 reports
Age 60137 reports
Age 72137 reports
Age 69134 reports
Age 56131 reports
Age 71126 reports
Age 74124 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CLOBETASOL PROPIONATE?

This profile reflects 20,397 FDA FAERS reports that mention CLOBETASOL PROPIONATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CLOBETASOL PROPIONATE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, PRURITUS, PSORIASIS, OFF LABEL USE, RASH, FATIGUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CLOBETASOL PROPIONATE?

Labeling and FAERS entries often list Galderma Laboratories, L.P. in connection with CLOBETASOL PROPIONATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.